Needle-free drug delivery market growing; Rosetta Genomics collaborates with Admera Health;

> The global needle-free drug delivery device market exceeds $4 billion, according to a market research report by Transparency Market Research. More

> RNA therapeutics company Rosetta Genomics announced a collaboration with global genomics company Admera Health. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.